Biolife Sciences (Biolife Sciences) COGS-to-Revenue : 0.80 (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences COGS-to-Revenue?

Biolife Sciences's Cost of Goods Sold for the three months ended in May. 2008 was $1.44 Mil. Its Revenue for the three months ended in May. 2008 was $1.80 Mil.

Biolife Sciences's COGS to Revenue for the three months ended in May. 2008 was 0.80.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biolife Sciences's Gross Margin % for the three months ended in May. 2008 was 19.80%.

Biolife Sciences COGS-to-Revenue Historical Data

The historical data trend for Biolife Sciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences COGS-to-Revenue Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

COGS-to-Revenue

0.83

0.82

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
COGS-to-Revenue	Get a 7-Day Free Trial										0.78	0.84	0.83	0.92	0.80

Biolife Sciences COGS-to-Revenue Calculation

Biolife Sciences's COGS to Revenue for the fiscal year that ended in Nov. 2007 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.037	/	8.603
	=	0.82

Biolife Sciences's COGS to Revenue for the quarter that ended in May. 2008 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.442	/	1.798
	=	0.80

Biolife Sciences (OTCPK:BLFE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biolife Sciences's Gross Margin % for the three months ended in May. 2008 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.442 / 1.798
	=	19.80 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biolife Sciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020